ExodusPoint Capital Management LP raised its position in shares of NanoString Technologies, Inc. (NASDAQ:NSTG – Free Report) by 216.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 130,309 shares of the biotechnology company’s stock after purchasing an additional 89,082 shares during the quarter. ExodusPoint Capital Management LP owned 0.28% of NanoString Technologies worth $1,290,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Point72 Middle East FZE bought a new position in NanoString Technologies in the 4th quarter worth $29,000. Point72 Hong Kong Ltd bought a new stake in NanoString Technologies during the 2nd quarter valued at approximately $57,000. Advisor Group Holdings Inc. boosted its stake in NanoString Technologies by 21.1% in the 1st quarter. Advisor Group Holdings Inc. now owns 4,595 shares of the biotechnology company’s stock worth $162,000 after purchasing an additional 800 shares during the period. Natixis purchased a new stake in NanoString Technologies during the 4th quarter valued at approximately $39,000. Finally, Tower Research Capital LLC TRC grew its holdings in NanoString Technologies by 181.5% during the 3rd quarter. Tower Research Capital LLC TRC now owns 5,705 shares of the biotechnology company’s stock valued at $73,000 after buying an additional 3,678 shares in the last quarter.
NanoString Technologies Stock Performance
NASDAQ NSTG opened at $2.58 on Monday. The business’s 50 day moving average price is $3.66 and its 200-day moving average price is $6.61. NanoString Technologies, Inc. has a fifty-two week low of $2.54 and a fifty-two week high of $16.47. The company has a debt-to-equity ratio of 16.67, a current ratio of 3.55 and a quick ratio of 2.76.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on NSTG. StockNews.com began coverage on shares of NanoString Technologies in a research report on Thursday, August 17th. They set a “sell” rating for the company. Robert W. Baird cut their price objective on NanoString Technologies from $13.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, August 4th. Finally, Morgan Stanley decreased their target price on NanoString Technologies from $15.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Monday, August 7th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, NanoString Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $16.83.
Check Out Our Latest Analysis on NSTG
NanoString Technologies Profile
NanoString Technologies, Inc develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.
See Also
- Five stocks we like better than NanoString Technologies
- How to Invest in Renewable Energy
- MarketBeat Week in Review – 8/28 – 9/1
- How to Invest in the Best Canadian Stocks
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- What Are the U.K. Market Holidays? How to Invest and Trade
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Want to see what other hedge funds are holding NSTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NanoString Technologies, Inc. (NASDAQ:NSTG – Free Report).
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.